1. Home
  2. CORT vs VIAV Comparison

CORT vs VIAV Comparison

Compare CORT & VIAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$63.63

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

N/A

Current Price

$26.73

Market Cap

9.0B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
VIAV
Founded
1998
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
9.0B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
CORT
VIAV
Price
$63.63
$26.73
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
★ $142.60
$56.00
AVG Volume (30 Days)
1.2M
★ 6.3M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.13
0.29
Revenue
$761,407,000.00
★ $1,518,300,000.00
Revenue This Year
$52.09
$34.44
Revenue Next Year
$44.73
$14.47
P/E Ratio
★ $57.37
$101.28
Revenue Growth
12.79
★ 40.03
52 Week Low
$28.66
$15.97
52 Week High
$126.38
$60.43

Technical Indicators

Market Signals
Indicator
CORT
VIAV
Relative Strength Index (RSI) 20.65 37.88
Support Level $30.24 $25.73
Resistance Level $122.93 $34.88
Average True Range (ATR) 4.77 2.51
MACD -0.14 0.02
Stochastic Oscillator 1.89 25.05

Price Performance

Historical Comparison
CORT
VIAV

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc is a world-wide leader in test and measurement and optical technologies. Its test and measurement, and resilient Position, Navigation and Timing (PNT) solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, it develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets. The company's segments are Network and Service Enablement (NSE); and Optical Security and Performance Products (OSP). Majority of revenue comes from NSE segment. It has presence in Americas, Asia-Pacific, and EMEA. Majority of revenue is from America.

Share on Social Networks: